About us

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers. International Conference on Retinoblastoma and Retinal Disorders aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Retinoblastoma and Retinal Disorders. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Retinoblastoma and Retinal Disorders.

Important Dates

Wed, May 13, 2026

Abstracts/Full-Text Paper Submission Deadline

Wed, May 27, 2026

Notification of Acceptance/Rejection

Mon, Apr 27, 2026

Final Paper (Camera Ready) Submission & Early Bird Registration Deadline

Thu, Aug 27, 2026

Conference Dates

Call For Paper

Investigation of corneal disease

Corneal ulceration

Epithelial keratitis and drug-induced epithelial keratitis

Corneal degeneration

Recurrent corneal erosion

Corneal transplantation

Miscellaneous corneal disorders

Corneal neovascularization

Retrochiasmatic visual pathways

Myasthenia gravis

Chronic progressive external ophthalmoplegia

Cerebromacular degeneration

Retinopathy of prematurity

Eye screening

Strabismus

Amblyopia, exotropia, esotropia

Superior oblique palsy

Retinoblastoma

Thyroid eye disease

Orbital trauma

Age-related macular degeneration

Myopic macular degeneration

Diabetic retinopathy

Color vision defects

Retinal tumors

Retinal artery occlusion

Retinal vein occlusion

Retinal detachment

We invite researchers, scholars, and practitioners to submit their original research papers for presentation at the conference. All submissions will be peer-reviewed and selected based on their quality and relevance to the conference themes.

Committee

Conference Committee

Jagadananda Ghosh

Henry Ford Health System, United States

Md. Naushad Khan

Jackson Laboratory CT, United States

Idrisa Saad

Massachusetts General Hospital, United States

Adedeji Okikiade

Ejyde International Education and Research Consultancy, LLC, United States

Ozioma Esther Onuselogu

Eastern Illinois University, United States

Snigdha Sahai

University of Alabama at Birmingham, United States

Shohreh Ghasemi

Augusta University, United States

Charles Shang

South Florida Proton Therapy Institute, United States

Khaled Mohammed

Mayo Clinic, United States

Sindhu Pokhriyal

Interfaith Medical Center, One Brooklyn Health, United States

Xiaolei Li

Temple University, United States

Peter Kalina Kalina Kalina

Mayo Clinic, United States

Salim Zulfiqar

Virginia Commonwealth University, United States

George Kroumpouzos

Warren Alpert Medical School, Brown University, United States

Tanvi Ranjan

Harvard University, United States

Anusha Vaddi

Virginia Commonwealth University School of Dentistry, United States

Harry Voulgarakis

St Josephs University, United States

Saurabh Singh

Albert Einstein College of Medicine, United States

Chirag Vyas

Massachusetts General Hospital, United States

Yue Qin

University of California San Diego, United States

Nutan Hebballi

UTHealth, United States

Divya Mirchandani

University of Texas - Medical Branch, United States

Suhail Rasool

TrueBinding Inc., United States

Silvia Smith

University of North Carolina, Pembroke, United States

Mingyang Xin